Sector › Medicine
Press Releases
全球首创抗炎代谢调节剂HTD1801完成2型糖尿病III期临床研究 展现持续52周的综合获益与安全性优势
HighTide Therapeutics Inc.
Oct 31, 2025 08:30 HKT/SGT
全球首創抗炎代謝調節劑HTD1801完成2型糖尿病III期臨床研究 展現持續52周的綜合獲益與安全性優勢
HighTide Therapeutics Inc.
Oct 31, 2025 08:30 HKT/SGT
HTD1801, a First-in-Class Anti-inflammatory Metabolic Modulator, Demonstrates Durable 52-Week Efficacy and Safety in Two Phase III Trials in Type 2 Diabetes Mellitus
HighTide Therapeutics Inc.
Oct 31, 2025 08:30 HKT/SGT
TruMerit's Peter Preziosi Elected President of the Conference of NGOs in Consultative Relationship With the United Nations
TruMerit
Oct 31, 2025 04:00 HKT/SGT
CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Ra Humanized Monoclonal Antibody Injection MG-K10 Accepted in China
China Medical System Holdings Limited
Oct 30, 2025 21:00 JST
CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Ra Humanized Monoclonal Antibody Injection MG-K10 Accepted in China
China Medical System Holdings Limited
Oct 30, 2025 20:00 HKT/SGT
康哲药业（867.HK;8A8.SG）长效抗IL-4Rα人源化单抗注射液MG-K10特应性皮炎适应症中国NDA已获受理
China Medical System Holdings Limited
Oct 30, 2025 18:27 HKT/SGT
康哲藥業（867.HK;8A8.SG）長效抗IL-4Rα人源化單抗注射液MG-K10特應性皮炎適應症中國NDA已獲受理
China Medical System Holdings Limited
Oct 30, 2025 18:27 HKT/SGT
Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders
Everest Medicines Limited
Oct 30, 2025 16:48 HKT/SGT
Olympus Introduces NBI+TXI(TM) Observation Mode to the EVIS X1(TM) Endoscopy System CV-1500 Video System Center
Olympus
Oct 30, 2025 16:00 HKT/SGT
Olympus Introduces NBI+TXI(TM) Observation Mode to the EVIS X1(TM) Endoscopy System CV-1500 Video System Center
Olympus
Oct 29, 2025 10:00 HKT/SGT
康哲藥業（867.HK; 8A8.SG）簽訂眼科藥物諾適得(R)與倍優適(R)經銷協議
China Medical System Holdings Limited
Oct 28, 2025 18:22 HKT/SGT